Amylyx Pharmaceuticals, Inc. (AMLX)
NASDAQ: AMLX · Real-Time Price · USD
17.97
-0.30 (-1.64%)
At close: Jul 6, 2026, 4:00 PM EDT
18.15
+0.18 (1.00%)
Pre-market: Jul 7, 2026, 8:07 AM EDT
Amylyx Pharmaceuticals Employees
Amylyx Pharmaceuticals had 136 employees as of December 31, 2025. The number of employees increased by 13 or 10.57% compared to the previous year.
Employees
136
Change (1Y)
13
Growth (1Y)
10.57%
Revenue / Employee
n/a
Profits / Employee
-$1,103,765
Market Cap
2.00B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 136 | 13 | 10.57% |
| Dec 31, 2024 | 123 | -261 | -67.97% |
| Dec 31, 2023 | 384 | 122 | 46.56% |
| Sep 30, 2023 | 374 | 137 | 57.81% |
| Jun 30, 2023 | 338 | 112 | 49.56% |
| Mar 31, 2023 | 296 | 91 | 44.39% |
| Dec 31, 2022 | 262 | 57 | 27.80% |
| Sep 30, 2022 | 237 | 127 | 115.45% |
| Jun 30, 2022 | 226 | 116 | 105.45% |
| Dec 31, 2021 | 205 | 171 | 502.94% |
| Sep 30, 2021 | 110 | 76 | 223.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Bausch Health Companies | 20,300 |
| Perrigo Company | 8,100 |
| Trulieve Cannabis | 5,000 |
| Phibro Animal Health | 2,475 |
| HUTCHMED (China) | 1,796 |
| ANI Pharmaceuticals | 970 |
| Prestige Consumer Healthcare | 890 |
| Supernus Pharmaceuticals | 778 |
AMLX News
- 3 days ago - Did Amylyx Pharmaceuticals, Inc. Insiders Breach their Fiduciary Duties to Shareholders? - PRNewsWire
- 12 days ago - Amylyx price target raised to $40, named a Best Idea at Guggenheim - TheFly
- 14 days ago - Amylyx to present data from first-in-human, dose-ranging Phase 1 Lumina trial - TheFly
- 14 days ago - Amylyx Pharmaceuticals to Present Data from First-in-Human, Dose-Ranging Phase 1 LUMINA Trial of AMX0114 in ALS at ENCALS 2026 - Business Wire
- 26 days ago - Amylyx Pharmaceuticals Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts
- 4 weeks ago - Amylyx Pharmaceuticals Announces Poster Presentations at ENDO 2026 - Business Wire
- 4 weeks ago - Amylyx Pharmaceuticals Transcript: AGM 2026 - Transcripts
- 7 weeks ago - Amylyx announces publication of Phase 2 open-label HELIOS trial data - TheFly